Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference25 articles.
1. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies;Murphy;Vet Microbiol,2018
2. Levels of feline infectious peritonitis virus in blood, effusions, and various tissues and the role of lymphopenia in disease outcome following experimental infection;Pedersen;Vet Microbiol,2015
3. Mutation in spike protein cleavage site and pathogenesis of feline coronavirus;Licitra;Emerg Infect Dis,2013
4. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;Wang;Cell Res,2020
5. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis;Pedersen;J Feline Med Surg,2018
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (Mpro) as Potential COVID-19 Therapies;Frontiers in Molecular Biosciences;2022-03-14
2. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery;Computers in Biology and Medicine;2022-03
3. Off Label Medication to Combat COVID-19: Review Results to Date;Coronaviruses;2021-04
4. Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease;Expert Review of Anti-infective Therapy;2020-12-07
5. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives;Frontiers in Molecular Biosciences;2020-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3